An Emerging Role of Long Noncoding RNAs as Novel Biomarkers for Breast Cancer Metastasis
Source abstract
Abstract
Breast cancer is a leading cause of cancer-related deaths among women both worldwide and in Poland. Consequently, ensuring equitable access to diagnostic tests for all populations is crucial, alongside the urgent need to develop new, minimally invasive methods for early cancer detection with a particular focus on metastasis. Long noncoding RNAs (lncRNAs) have emerged as critical regulators of cancer metastasis. This review aims to investigate the potential of lncRNAs as novel biomarkers for breast cancer, focusing on their mechanisms, clinical relevance, and therapeutic implications. A comprehensive literature search was conducted using PubMed and Google Scholar databases, targeting publications from 2013 to 2024. Keywords included “lncRNA”, “biomarker”, “breast cancer”, “metastasis”, “prognosis”, and “diagnosis”. A total of 111 articles were selected based on their relevance and quality. Recent studies have identified numerous lncRNAs such as HOTAIR, MALAT1, BANCR, NEAT1, H19, and GAS5 as key regulators of various metastatic processes in breast cancer. They can be both upregulated and downregulated. Clinical studies have shown that abnormal lncRNA expression correlates with poor prognosis, higher metastatic potential, and therapy resistance in breast cancer patients. LncRNAs have significant potential as novel biomarkers for breast cancer metastasis because of their regulatory roles in metastasis-related processes and detectability in body fluids. Further research is essential to validate these findings in larger clinical studies and to develop lncRNA-based diagnostic and therapeutic tools, ultimately improving patient outcomes in breast cancer.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Student Research Group, Department of Human Physiology of the Chair of Preclinical Sciences, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland
Department of Human Physiology of the Chair of Preclinical Sciences, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland
References (100+)
Show source-provided references
1. Molecular classification of breast cancer: A retrospective cohort study
2. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion
3. Cancer incidence and mortality in Poland in 202010.5603/NJO.2023.0026 ↗
4. Burzyńska, M., Maniecka-Bryła, I., and Pikala, M. (2020). Trends of mortality due to breast cancer in Poland, 2000–2016. BMC Public Health, 20.10.1186/s12889-020-8256-1 ↗
5. Inequalities in breast cancer incidence and stage distribution between urban and rural female population in Świętokrzyskie Province, Poland10.26444/aaem/102380 ↗
6. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer10.1007/s10549-013-2776-7 ↗
7. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer10.18632/aging.102783 ↗
8. Landscape of somatic mutations in 560 breast cancer whole-genome sequences10.1038/nature17676 ↗
9. Impact of TP53 mutations in Triple Negative Breast Cancer10.1038/s41698-022-00303-6 ↗
10. HER2-positive breast cancer10.1016/S0140-6736(16)32417-5 ↗
11. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study10.1038/s41591-019-0582-4 ↗
12. Expression Analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in Breast Cancer Tissues from Young Women and Women over 45 Years of Age10.1016/j.omtn.2018.07.014 ↗
13. Long non-coding RNA mediated drug resistance in breast cancer10.1016/j.drup.2022.100851 ↗
14. LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer10.7150/jca.29670 ↗
15. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines10.1002/stem.1547 ↗
16. Wang, Y., Zhou, Y., Yang, Z., Chen, B., Huang, W., Liu, Y., and Zhang, Y. (2017). MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer. Tumour Biol., 39.10.1177/1010428317690998 ↗
17. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway
18. Modulation of hypoxia-signaling pathways by extracellular linc-RoR
19. Paracrine and epigenetic control of CAF-induced metastasis: The role of HOTAIR stimulated by TGF-ß1 secretion10.1186/s12943-018-0758-4 ↗
20. LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling10.1038/s41388-023-02652-3 ↗
21. Wang, J., Liu, X., Li, P., Wang, J., Shu, Y., Zhong, X., Gao, Z., Yang, J., Jiang, Y., and Zhou, X. (2022). Long noncoding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-κB signaling pathway. J. Biol. Chem., 298.10.21203/rs.3.rs-1472670/v1 ↗
22. A Novel Long Non-Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis10.1002/advs.202002232 ↗
23. Identification and validation of immune-related lncRNA prognostic signature for breast cancer10.1016/j.ygeno.2020.02.015 ↗
24. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer10.1007/s12282-020-01048-5 ↗
25. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis10.1038/s41419-023-05609-2 ↗
26. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer10.1038/onc.2015.340 ↗
27. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway
28. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p10.1016/j.bj.2020.11.002 ↗
29. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK10.18632/oncotarget.13263 ↗
30. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients10.1016/j.jmoldx.2021.07.014 ↗
31. A Comparative Study of HOTAIR Expression in Breast Cancer Patient Tissues and Cell Lines
32. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers10.1038/srep08765 ↗
33. Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer10.1186/s12967-015-0489-x ↗
34. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer10.1007/s10549-015-3431-2 ↗
35. Lozano-Romero, A., Astudillo-de la Vega, H., Terrones-Gurrola, M.C.D.R., Marchat, L.A., Hernández-Sotelo, D., Salinas-Vera, Y.M., Ramos-Payan, R., Silva-Cázares, M.B., Nuñez-Olvera, S.I., and Hernández-de la Cruz, O.N. (2020). HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204/FAK Axis in Triple Negative Breast Cancer Cells. Noncoding RNA, 6.10.3390/ncrna6020019 ↗
36. Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer10.2147/OTT.S155134 ↗
37. MALAT1 promotes angiogenesis of breast cancer
38. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer10.18632/oncotarget.9622 ↗
39. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer10.4103/jcrt.JCRT_282_19 ↗
40. Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer
41. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer
42. Long noncoding RNA MALAT1 suppresses breast cancer metastasis10.1038/s41588-018-0252-3 ↗
43. A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers10.1002/ijc.31386 ↗
44. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer
45. Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer10.1038/bjc.2016.123 ↗
46. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer
47. The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers10.1038/s41598-020-57759-4 ↗
48. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness10.1038/s41419-019-1513-5 ↗
49. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer10.1016/j.ijbiomac.2017.07.053 ↗
50. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer10.1172/JCI94233 ↗
51. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis10.18632/oncotarget.11364 ↗
52. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival10.1038/onc.2014.378 ↗
53. Peperstraete, E., Lecerf, C., Collette, J., Vennin, C., Raby, L., Völkel, P., Angrand, P.-O., Winter, M., Bertucci, F., and Finetti, P. (2020). Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions. Cancers, 12.10.3390/cancers12071730 ↗
54. Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population10.2147/OTT.S127962 ↗
55. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b10.18632/oncotarget.4976 ↗
56. Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer
57. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer10.3233/CBM-160630 ↗
58. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis10.2147/OTT.S243601 ↗
59. Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis10.12659/MSM.912581 ↗
60. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer10.18632/oncotarget.8413 ↗
61. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p10.1016/j.biopha.2018.05.056 ↗
62. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling10.1002/jcb.29445 ↗
63. Long non-coding RNA growth arrest-specific 5 (GAS5) acts as a tumor suppressor by promoting autophagy in breast cancer10.3892/mmr.2020.11334 ↗
64. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects10.1007/s13277-015-4568-7 ↗
65. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: A predictor classification model10.2217/epi-2019-0291 ↗
66. Expression patterns of LncRNA-GAS5 and its target APOBEC3C gene through miR-103 in breast cancer patients10.14715/cmb/2021.67.3.2 ↗
67. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production10.1002/jcp.30234 ↗
68. LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer10.1007/s13577-019-00273-1 ↗
69. Long non-coding RNA HEIH promotes breast cancer development via negative modulation of microRNA-200b
70. lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer
71. Long Noncoding RNAs in Cancer Pathways10.1016/j.ccell.2016.03.010 ↗
72. The potential roles of lncRNA TINCR in triple negative breast cancer10.1007/s11033-023-08661-5 ↗
73. LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer10.1038/s41419-020-03188-0 ↗
74. Gibbons, H.R., Shaginurova, G., Kim, L.C., Chapman, N., Spurlock, C.F., and Aune, T.M. (2018). Divergent lncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells. Front. Immunol., 9.10.3389/fimmu.2018.02512 ↗
75. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer10.1038/s41419-019-2062-7 ↗
76. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L110.1111/cpr.12855 ↗
77. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression10.1139/bcb-2018-0168 ↗
78. Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer10.1038/s41419-018-1210-9 ↗
79. Study on the Expression of lncRNA ATB and Nek9 in Breast Cancer Patients Based on Q-PCR Technology and Its Relationship with the Disease10.1155/2022/2634080 ↗
80. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer10.1016/j.lfs.2020.118193 ↗
81. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis10.1158/0008-5472.CAN-18-1102 ↗
82. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis10.1172/JCI91553 ↗
83. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer10.1038/cdd.2016.95 ↗
84. The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence10.1038/s41598-017-12716-6 ↗
85. lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells10.1158/1541-7786.MCR-21-0137 ↗
86. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis10.1016/j.ccell.2015.02.004 ↗
87. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer10.1002/ijc.31605 ↗
88. An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer10.1038/s41418-018-0123-6 ↗
89. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis10.1038/cddis.2014.249 ↗
90. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells10.1007/s13277-016-4909-1 ↗
91. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers10.1097/MD.0000000000006222 ↗
92. Long non-coding RNAs AC026904.1 and UCA1: A “one-two punch” for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer10.7150/thno.23463 ↗
93. Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer10.1158/0008-5472.CAN-18-3418 ↗
94. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling10.18632/aging.102080 ↗
95. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer
96. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells10.1016/j.phrs.2020.104628 ↗
97. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation10.1038/s41419-019-1566-5 ↗
98. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis10.1007/s10585-018-9901-2 ↗
99. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC210.18632/oncotarget.5609 ↗
100. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer10.1016/j.biopha.2017.09.076 ↗